Marshall Wace North America’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $301K | Buy |
+7,200
| New | +$301K | ﹤0.01% | 1187 |
|
|
2020
Q4 | – | Sell |
-171,862
| Closed | -$4.73M | – | 1533 |
|
|
2020
Q3 | $4.73M | Sell |
171,862
-175,199
| -50% | -$4.82M | 0.03% | 407 |
|
|
2020
Q2 | $12.8M | Buy |
347,061
+87,514
| +34% | +$3.22M | 0.08% | 236 |
|
|
2020
Q1 | $8.4M | Buy |
+259,547
| New | +$8.4M | 0.06% | 243 |
|
|
2018
Q2 | – | Sell |
-223,901
| Closed | -$6.68M | – | 1632 |
|
|
2018
Q1 | $6.68M | Buy |
223,901
+183,650
| +456% | +$5.48M | 0.03% | 494 |
|
|
2017
Q4 | $1.34M | Buy |
+40,251
| New | +$1.34M | 0.01% | 927 |
|
|
2017
Q3 | – | Sell |
-24,526
| Closed | -$491K | – | 1460 |
|
|
2017
Q2 | $491K | Buy |
+24,526
| New | +$491K | ﹤0.01% | 1095 |
|